| 2022-03-01 | Roskey Mark T. | SVP, Strategic Partnerships | Sell | 44 | $32.15 | $1,414.60 | -0.2% | → |
| 2022-02-09 | Roskey Mark T. | SVP, Strategic Partnerships | Sell | 292 | $34.97 | $10,210.83 | -1.3% | → |
| 2022-02-09 | Fry John J | General Counsel & Secretary | Sell | 481 | $34.97 | $16,819.90 | -1.5% | → |
| 2022-02-09 | HRUSOVSKY E KEVIN | Chairman and CEO | Sell | 1,364 | $34.97 | $47,697.17 | -0.2% | → |
| 2022-02-09 | Mattoon Dawn | Sr. VP, Diagnostics | Sell | 318 | $34.97 | $11,120.01 | -0.8% | → |
| 2022-02-04 | Duffy David C. | SVP R&D and CTO | Sell | 3,266 | $30.91 | $100,952.06 | -5.3% | → |
| 2022-02-02 | HRUSOVSKY E KEVIN | Chairman and CEO | Sell | 589 | $31.46 | $18,529.74 | - | → |
| 2022-02-02 | Mattoon Dawn | Sr. VP, Diagnostics | Sell | 267 | $31.46 | $8,399.14 | -0.4% | → |
| 2022-02-02 | Roskey Mark T. | SVP, Strategic Partnerships | Sell | 166 | $31.46 | $5,221.81 | -0.4% | → |
| 2022-02-02 | Fry John J | General Counsel & Secretary | Sell | 371 | $31.46 | $11,671.05 | -0.6% | → |
| 2022-01-31 | Duffy David C. | SVP R&D and CTO | Sell | 3,266 | $30.00 | $97,980.00 | -5.1% | → |
| 2022-01-03 | Fry John J | General Counsel & Secretary | Sell | 352 | $41.91 | $14,751.12 | -1.1% | → |
| 2022-01-03 | Mattoon Dawn | Sr. VP, Diagnostics | Sell | 355 | $41.91 | $14,876.84 | -0.9% | → |
| 2022-01-03 | Roskey Mark T. | SVP, Strategic Partnerships | Sell | 149 | $41.91 | $6,244.08 | -0.6% | → |
| 2022-01-03 | HRUSOVSKY E KEVIN | Chairman and CEO | Sell | 3,715 | $41.91 | $155,683.02 | -0.4% | → |
| 2021-12-29 | Duffy David C. | SVP R&D and CTO | Sell | 1,667 | $40.71 | $67,863.57 | -6.7% | → |
| 2021-12-01 | HRUSOVSKY E KEVIN | Chairman and CEO | Sell | 3,710 | $40.29 | $149,476.93 | -0.2% | → |
| 2021-12-01 | Mattoon Dawn | Sr. VP, Diagnostics | Sell | 353 | $40.29 | $14,222.13 | -0.5% | → |
| 2021-12-01 | Fry John J | General Counsel & Secretary | Sell | 350 | $40.29 | $14,101.33 | -0.5% | → |
| 2021-12-01 | Roskey Mark T. | SVP, Strategic Partnerships | Sell | 147 | $40.29 | $5,922.53 | -0.3% | → |
| 2021-11-19 | Duffy David C. | SVP R&D and CTO | Sell | 1,667 | $45.54 | $75,915.18 | -6.3% | → |
| 2021-11-10 | HRUSOVSKY E KEVIN | Chairman and CEO | Sell | 5,000 | $55.18 | $275,897.48 | -0.2% | → |
| 2021-11-05 | Mattoon Dawn | Sr. VP, Diagnostics | Sale+OE | 8,536 | $57.28 | $488,908.42 | -7.0% | → |
| 2021-11-02 | Fry John J | General Counsel & Secretary | Sell | 331 | $52.61 | $17,412.31 | -0.5% | → |
| 2021-11-02 | Mattoon Dawn | Sr. VP, Diagnostics | Sell | 333 | $52.61 | $17,517.85 | -0.5% | → |
| 2021-11-02 | HRUSOVSKY E KEVIN | Chairman and CEO | Sell | 3,505 | $52.61 | $184,384.69 | -0.2% | → |
| 2021-11-02 | Roskey Mark T. | SVP, Strategic Partnerships | Sell | 139 | $52.61 | $7,312.39 | -0.3% | → |
| 2021-10-22 | HRUSOVSKY E KEVIN | Chairman and CEO | Sell | 5,000 | $50.70 | $253,519.89 | -0.2% | → |
| 2021-10-15 | Duffy David C. | SVP R&D and CTO | Sell | 1,667 | $51.47 | $85,800.49 | -5.9% | → |
| 2021-10-01 | Roskey Mark T. | SVP, Strategic Partnerships | Sell | 143 | $51.20 | $7,321.69 | -0.6% | → |
| 2021-10-01 | Mattoon Dawn | Sr. VP, Diagnostics | Sell | 342 | $51.20 | $17,510.61 | -0.9% | → |
| 2021-10-01 | Fry John J | General Counsel & Secretary | Sell | 340 | $51.20 | $17,408.20 | -1.0% | → |